Patents by Inventor Fanny O'Brien

Fanny O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-C5 ANTIBODY FOR THE TREATMENT OF NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Publication number: 20230043034
    Abstract: Provided are methods for clinical treatment of neuromyelitis optica spectrum disorder (NMOSD) using an anti-C5 antibody, or antigen binding fragment thereof.
    Type: Application
    Filed: December 8, 2020
    Publication date: February 9, 2023
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Kerstin Allen, Marcus Yountz, Stephan Ortiz, Fanny O'Brien
  • METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB
    Publication number: 20220259305
    Abstract: The disclosure provides methods of treating refractory myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody. In certain embodiments, the patient achieves and maintains the status of improved or MM according to the MGFA Post-Intervention Status.
    Type: Application
    Filed: August 4, 2020
    Publication date: August 18, 2022
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Jing Jing Wang, Warren Wasiewski, Fanny O'Brien, Kenji Fujita
  • METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS
    Publication number: 20210246196
    Abstract: The disclosure provides methods of treating myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody.
    Type: Application
    Filed: January 15, 2021
    Publication date: August 12, 2021
    Inventors: Camille Bedrosian, Fanny O'Brien, Jing Jing Wang
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA
    Publication number: 20200095307
    Abstract: Provided are methods of treating neuromyelitis optica spectrum disorder (NMOSD) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In some embodiments, the substance that specifically binds C5 is a binding protein, e.g., an anti-C5 antibody.
    Type: Application
    Filed: September 20, 2019
    Publication date: March 26, 2020
    Inventor: Fanny O'Brien
  • Methods for Treatment of Refractory Generalized Myasthenia Gravis
    Publication number: 20170342139
    Abstract: The disclosure provides methods of treating myasthenia gravis (MG) in a subject in need thereof by administering to the subject a substance that specifically binds complement component 5 (C5). In certain embodiments, the substance that specifically binds C5 is a binding protein, such as an anti-C5 antibody.
    Type: Application
    Filed: May 15, 2017
    Publication date: November 30, 2017
    Inventors: Camille Bedrosian, Fanny O'Brien, Jing Jing Wang